VWR Buys Biochemical, Reagent Firm Amresco | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – VWR International today announced the acquisition of Amresco for an undisclosed amount.

Based in Solon, Ohio, Amresco manufactures and supplies biochemicals and reagents for use in research in the molecular biology, life sciences, proteomics, clinical, and histology markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.